POULIOT, Frédéric et al. Trajectory timelines and treatment efficacy of 177Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer: Real-world data from 50 consecutive cases treated in a single Canadian center. Canadian Urological Association Journal, [S. l.], v. 20, n. 6, 2026. DOI: 10.5489/cuaj.9398. Disponível em: https://cuaj.ca/index.php/journal/article/view/9398. Acesso em: 30 apr. 2026.